M
Medaxion
Anesthesia EHR Software: Electronic Health Records | Medaxion
About Medaxion
Medaxion operates in the healthcare technology sector, specializing in anesthesia and pharmacy data management. The company provides a comprehensive Electronic Health Record (EHR) platform designed to optimize Operating Room (OR) performance and revenue. Medaxion serves hospitals and health systems by closing information gaps and identifying lost revenue opportunities. Its core products include Medaxion Pulse, an anesthesia EHR platform, Medaxion Sync, which synchronizes multi-source anesthesia data, and Medaxion Advance Pharmacy, which aggregates point-of-care OR drug data. The business model is based on a subscription service, where clients pay for access to the platform and its analytics capabilities. Medaxion generates revenue through these subscriptions and potentially through additional services such as data analytics and consulting. The market it operates in is the healthcare technology industry, specifically focusing on OR efficiency and data management.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2008
- Headquarters
- Nashville, United States
- Employees
- 50
- Open positions
- None listed
- Dealroom signal
- 63.5/100
- Industry
- Health
- Sub-industry
- BioTechnology, Health Platform
- Sector
- Biotech & Life Sciences, Testing, Electronic Health Records (EHR), Verification, Biotechnology, Biotech and Pharma, Hard Tech, medical testing, DT and LS, science-based
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Jul 2023 | $20M | $80M | Undisclosed | ↗ |
| EARLY VC✓Equity / VC | May 2018 | $500K | $2M | Undisclosed | — |
Growth signals
Latest recorded traffic for Medaxion is 3K monthly website visits, up 219.1% over the last three months. Medaxion's team declined 3.8% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Petra Capital Partners
Other known investors1 additional known investor
M-One Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Medaxion on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Medaxion’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.






